Cargando…

Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32

Immune dysregulation diseases are characterized by heterogeneous clinical manifestations and may have severe disease courses. The identification of the genetic causes of these diseases therefore has critical clinical implications. We performed whole-exome sequencing of patients with immune dysregula...

Descripción completa

Detalles Bibliográficos
Autores principales: Lehmkuhl, Peter, Gentz, Magdalena, Garcia de Otezya, Andres Caballero, Grimbacher, Bodo, Schulze-Koops, Hendrik, Skapenko, Alla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245512/
https://www.ncbi.nlm.nih.gov/pubmed/34059789
http://dx.doi.org/10.1038/s41423-021-00701-z
_version_ 1783716128488423424
author Lehmkuhl, Peter
Gentz, Magdalena
Garcia de Otezya, Andres Caballero
Grimbacher, Bodo
Schulze-Koops, Hendrik
Skapenko, Alla
author_facet Lehmkuhl, Peter
Gentz, Magdalena
Garcia de Otezya, Andres Caballero
Grimbacher, Bodo
Schulze-Koops, Hendrik
Skapenko, Alla
author_sort Lehmkuhl, Peter
collection PubMed
description Immune dysregulation diseases are characterized by heterogeneous clinical manifestations and may have severe disease courses. The identification of the genetic causes of these diseases therefore has critical clinical implications. We performed whole-exome sequencing of patients with immune dysregulation disorders and identified two patients with previously undescribed mutations in LRRC32, which encodes glycoprotein A repetitions predominant (GARP). These patients were characterized by markedly reduced numbers and frequencies of regulatory T cells (Tregs). Tregs with mutated LRRC32 exhibited strongly diminished cell-surface GARP expression and reduced suppressor function. In a model of conditional Garp deficiency in mice, we confirmed increased susceptibility to inflammatory diseases once GARP expression on Tregs was decreased. Garp deficiency led to an unstable Treg phenotype due to diminished Foxp3 protein acetylation and stability. Our study reinforces the understanding of the immunological mechanisms of immune dysregulation and expands the knowledge on the immunological function of GARP as an important regulator of Treg stability.
format Online
Article
Text
id pubmed-8245512
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82455122021-07-20 Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32 Lehmkuhl, Peter Gentz, Magdalena Garcia de Otezya, Andres Caballero Grimbacher, Bodo Schulze-Koops, Hendrik Skapenko, Alla Cell Mol Immunol Article Immune dysregulation diseases are characterized by heterogeneous clinical manifestations and may have severe disease courses. The identification of the genetic causes of these diseases therefore has critical clinical implications. We performed whole-exome sequencing of patients with immune dysregulation disorders and identified two patients with previously undescribed mutations in LRRC32, which encodes glycoprotein A repetitions predominant (GARP). These patients were characterized by markedly reduced numbers and frequencies of regulatory T cells (Tregs). Tregs with mutated LRRC32 exhibited strongly diminished cell-surface GARP expression and reduced suppressor function. In a model of conditional Garp deficiency in mice, we confirmed increased susceptibility to inflammatory diseases once GARP expression on Tregs was decreased. Garp deficiency led to an unstable Treg phenotype due to diminished Foxp3 protein acetylation and stability. Our study reinforces the understanding of the immunological mechanisms of immune dysregulation and expands the knowledge on the immunological function of GARP as an important regulator of Treg stability. Nature Publishing Group UK 2021-05-31 2021-07 /pmc/articles/PMC8245512/ /pubmed/34059789 http://dx.doi.org/10.1038/s41423-021-00701-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lehmkuhl, Peter
Gentz, Magdalena
Garcia de Otezya, Andres Caballero
Grimbacher, Bodo
Schulze-Koops, Hendrik
Skapenko, Alla
Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
title Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
title_full Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
title_fullStr Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
title_full_unstemmed Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
title_short Dysregulated immunity in PID patients with low GARP expression on Tregs due to mutations in LRRC32
title_sort dysregulated immunity in pid patients with low garp expression on tregs due to mutations in lrrc32
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245512/
https://www.ncbi.nlm.nih.gov/pubmed/34059789
http://dx.doi.org/10.1038/s41423-021-00701-z
work_keys_str_mv AT lehmkuhlpeter dysregulatedimmunityinpidpatientswithlowgarpexpressionontregsduetomutationsinlrrc32
AT gentzmagdalena dysregulatedimmunityinpidpatientswithlowgarpexpressionontregsduetomutationsinlrrc32
AT garciadeotezyaandrescaballero dysregulatedimmunityinpidpatientswithlowgarpexpressionontregsduetomutationsinlrrc32
AT grimbacherbodo dysregulatedimmunityinpidpatientswithlowgarpexpressionontregsduetomutationsinlrrc32
AT schulzekoopshendrik dysregulatedimmunityinpidpatientswithlowgarpexpressionontregsduetomutationsinlrrc32
AT skapenkoalla dysregulatedimmunityinpidpatientswithlowgarpexpressionontregsduetomutationsinlrrc32